ADAM12 and nonpapillary renal cell carcinoma: TCGA database revealed that ADAM12 was significantly upregulated in ccRCC tissues and was positively correlated with T stage and tumor stage in ccRCC patients (p < 0.001) (Fig. 1A–C).